What is the main business of META Pharmaceutical Production?

The main business activity of META Pharmaceutical Production focuses on manufacture of pharmaceutical preparations.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on September 22, 2022.

Where is the headquarters located?

The headquarters is located at: ul. Akacjowa 4N, 55-040 Ślęza.

What is the share capital?

The share capital of the company is PLN 5,305,000 (approx. $1.4 million).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What revenue was generated?

The company reported a revenue of $107,223 in 2024, which is an increase of 327.9% compared to 2023.

Is the company profitable?

No, the company recorded a net loss of $251,580 in 2024. For comparison, in 2023 the loss was $320,040, meaning the company reduced its loss by 25.3%.

Which cost dominates operating expenses?

The largest operating cost category falls under employee remuneration. This category amounted to $160,603 in 2024, representing 58% of all operating expenses.

Meta Pharmaceutical Productionsp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2022-09-22

Share capital

5,305,000.00 PLN

Activity description

Meta Pharmaceutical Production distributes pharmaceutical ingredients for compounding and produces dietary supplements under its own brands and on a contract basis. The group also works with foods for special medical purposes, promotes compounded medicines, and manages marketing authorisations for medicinal products.

Registered address

ul. Akacjowa 4N/2/10, 55-040 Ślęza, Poland

Website

metapharmaceutical.pl

Phone

Electronic delivery address

AE:PL-15827-65767-DIBBJ-22

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 9 days early.

202508/07/2026
202414/07/2025
202327/06/2024

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 41.27kMedianUSD 917.74kAverageUSD 25.73m

Net profit

This companyUSD -176.93kMedianUSD 14.44kAverageUSD 2.75m

Operating costs

This companyUSD 210.14kMedianUSD 860.03kAverageUSD 21.34m

Assets

This companyUSD 959.80kMedianUSD 883.09kAverageUSD 31.39m

News

2025-04-03

PIHZ certificate confirming Meta Pharmaceutical Production compliance with ISO 22000:2018

Industry

Offer

Pharmaceutical raw materials
Dietary supplements
Food for special medical purposes
Micro-pellets

Certifications: ISO 22000

Website technology

Website

WordPress

Analytics and marketing

Google Analytics

Authorized Representatives

Agnieszka Bilicka Krakowiak – Attorney-in-fact (sole)

Tomasz Krakowiak – President of the Management Board

Manner of representation

In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

Owner	Shares	Share value	Stake
Miasto Sejny	20,020	$540,788.76	37.738%
Others	33,030	$892,220.42	62.262%

Beneficial owners

Person	Rights

Subsidiaries

	Name	Share value	Stake
	META Pharmaceutical Healthcaresp. z o.o.	224,203.13 USD	100%

Bank accounts

Registered as a VAT taxpayer on 2022-11-16.

PKO Bank Polski
63 1020 3352 0000 1102 0322 8129
PKO Bank Polski
70 1020 3352 0000 1102 0291 2947

Debt

No entries in the National Debtors Register (KRZ).

Real estate

Type	Amount
Land (incl. perpetual usufruct)	$408.3K$408,342

MSiG notices

Publication date	Event
Mar 28, 2025	Call to creditors

Public aid

No public aid cases recorded in the last 10 years.

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Competitors

Name	Revenue	Website
F1 PharmaS.A.	$272,113.66	f1pharma.pl
Pexon Polandsp. z o.o.	$122,615.96	pexon.pl
Quantum Biomedsp. z o.o.	$13,877.54	quantum-biomed.pl

Change history

Date	Event
2025-10-24	Address change (Ul. Józefa Piłsudskiego 25, 16-500, Sejny → Ul. Akacjowa 4n/2/10, 55-040, Ślęza)
2024-09-17	Share capital increase (5,005,000.00 PLN → 5,305,000.00 PLN)
2024-04-15	Name change (Mt-Pharma Sejny → Meta Pharmaceutical Production)
2024-01-23	PKD change (Removed: 8 codes; Added: 10 codes)
2023-02-14	Share capital increase (5,000.00 PLN → 5,005,000.00 PLN)

FAQ

Last updated: 2026-10-07